
The episode discusses the development of AI-powered personalized mRNA cancer vaccines by Likang Life Sciences and the entrepreneurial journey of its founder, Chen Li.
Program description: Darers and Doers, a special segment of China Business Uncovered, showcases groundbreaking innovations from China and features company founders and CEOs who are turning cool, bold ideas into reality. Produced by Caixin Global. Episode intro: Cancer treatment has long relied on a largely fixed set of options: surgery, radiation, chemotherapy and targeted drugs. But a new generation of biotech founders is trying to push the field toward something more precise — treatments built around the biology of a single patient. In this debut episode of Darers & Doers, Likang Life Sciences Founder and CEO Chen Li explains how his Beijing-based biotech startup is using artificial intelligence to develop personalized mRNA cancer vaccines. Chen's entrepreneurial journey began with the cancer diagnosis of his mother, who later became his company's first patient. Ten years on, Likang's product, LK101, is already being used on patients in South China's Hainan province under a pilot policy, has won FDA approval, and is now advancing toward international clinical development. Speaking with Caixin Global Managing Director Li Xin, Chen discusses how his approach aims to overcome the…
Host: Li Xin
Guest: Chen Li
Organizations: Likang Life Sciences, FDA
Products: LK101
Places: Beijing, South China, Hainan province
Explore listener stats, chart rankings, contacts and more on the China Business Insider - News From Caixin Global podcast page.